Autoinjectors Market by Application, End-user, and Geography - Forecast and Analysis 2023-2027

Published: Mar 2023 Pages: 165 SKU: IRTNTR70391

The autoinjectors market size is estimated to grow at a CAGR of 25.14% between 2022 and 2027. The autoinjectors market size is forecast to increase by USD 134,014.58 million. The growth of the market depends on several factors, including the increasing prevalence of allergies and need for immediate care, the growing popularity of injectable therapies, and the rise in commercial approvals of new products.

This autoinjectors market report extensively covers market segmentation by application (anaphylaxis, multiple sclerosis, rheumatoid arthritis, and diabetes), end-user (hospitals and clinics, and self-administration), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Autoinjectors Market During the Forecast Period?

To learn more about this report, View Report Sample

Autoinjectors Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increasing prevalence of allergies and need for immediate care are notably driving the market growth, although factors such as side-effects of autoinjectors may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Autoinjectors Market Driver

Increasing prevalence of allergies and need for immediate care is the key factor driving the growth of the global autoinjectors market. Globally, the prevalence of allergies to food items, pollens, food additives, latex, and dust and the risk of contracting anaphylaxis caused by these factors are increasing. According to CDC, allergies are the sixth leading cause of chronic illness in the US, with an annual expenditure of more than $18 billion. More than 50 million North American are affected by allergies each year. On average, 30%-35% of the global population is diagnosed with an allergy annually. Canada is witnessing an increase in healthcare spending that will further propel the North American market during the forecast period.

The Brazilian auto-injector market is expected to grow during the forecast period, owing to the country's economic growth, improved access to remote medical facilities, and rising awareness of auto-injectors in the country. The high prevalence of anaphylaxis in the United States leads to high adoption of generic epinephrine auto-injectors. Autoinjectors can treat symptoms with a small dose of epinephrine. These autoinjectors help restore normal breathing, increase blood pressure if it is dropping, and reduce swelling. With the increasing occurrence of allergies, the growth prospects of epinephrine autoinjectors are likely to rise, as they can be self-administered during sudden anaphylactic attacks. Therefore, the increasing prevalence of allergies and the need for immediate care will boost the growth of the global autoinjectors market during the forecast period.

Significant Autoinjectors Market Trends

Strategic alliances between companies is the primary trend in the global autoinjectors market. Strategic alliances in the global autoinjector market are on the rise, with several acquisitions/partnerships aimed at expanding the business by offering new mineral cosmetics. For instance, Pfizer Inc. works in association with Antares Pharma to develop an autoinjector pen for an undisclosed Pfizer drug. Pfizer product utilizes Antares Pharma patented QuickShot autoinjector and an unrevealed drug.

Moreover, Pfizer Inc. will obtain the US FDA approval and marketing permission for the combination product in the coming years. The development agreement between Antares Pharma and Pfizer aims to expand the portfolio of pipeline partners' products. Further, such strategic alliances will help Pfizer Inc. increase the potential number of products utilizing Antares Pharma innovative QuickShot autoinjector technology platform. Thus, an increase in strategic alliances is expected to boost the growth of the global autoinjectors market during the forecast period.

Major Autoinjectors Market Challenge

Side-effects of autoinjectors is a major challenge to the growth of the global autoinjectors market. Using autoinjectors causes several side effects such as infections, high and low blood pressure, muscle pain, headache, and diarrhea. Patients with chemotherapy-induced anemia show an increased incidence of fatigue, edema, nausea, vomiting, fever, and hypertension. MS patients administered with autoinjectors are vulnerable to severe hepatic injury, including cases of hepatic failure. In certain cases, interferon beta-1 b-filled autoinjectors for such patients can also cause anaphylaxis.

Other allergic reactions may include dyspnea, bronchospasm, tongue edema, skin rash, and urticaria. Thus, the associated side effects can impact the adoption of autoinjectors and encourage patients to opt for alternatives with less severe side effects. Thus, the side effects of autoinjectors are expected to be slowed down the growth of the global autoinjectors market during the forecast period.

Key Autoinjectors Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Autoinjectors Market Customer Landscape

Who are the Major Autoinjectors Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

AbbVie Inc.: The company offers autoinjectors namely, Adalimumab. Also, under this segment, the company conducts research and development, manufacturing, commercialization and sale of innovative medicines and therapies to allocate resources and assess business performance on a global basis in order to achieve established long-term strategic goals.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • Amgen Inc.
  • Bayer AG
  • Becton Dickinson and Co.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Halozyme Therapeutics Inc.
  • Johnson and Johnson Services Inc.
  • Johnson Medtech LLC
  • medmix Ltd.
  • Merck KGaA
  • Owen Mumford Ltd.
  • Pfizer Inc.
  • RAVIMED Sp. zoo
  • Recipharm AB

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segments in the Autoinjectors Market?

The market share growth by the anaphylaxis segment will be significant during the forecast period. The anaphylaxis segment generates the highest revenue because of the increasing prevalence of anaphylaxis and food allergies at a global level. For instance, according to the Centers for Disease Control and Prevention (CDC), around 8% of children in the US have food allergies. 

Get a glance at the market contribution of various segments View the PDF Sample

The anaphylaxis segment was valued at USD 19,989.44 million in 2017 and continued to grow until 2021. Anaphylaxis is an acute, potentially fatal condition that is often a response to an allergen. One of the most effective treatments for anaphylaxis is the intramuscular administration of epinephrine, and it is the first line of treatment drugs. There are many auto-injector suppliers in the global market that offer epinephrine auto-injectors specifically for anaphylaxis. Therefore, the availability in the market of auto-injectors that enable self-administration of anaphylaxis medications and vendor support in demonstrating the process of self-administration are expected to propel this segment, making it the global automotive market. 

Which are the Key Regions for the Autoinjectors Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Canada is witnessing an increase in healthcare spending that will further propel the North American market during the forecast period. The Brazilian auto-injector market is expected to grow during the forecast period, owing to the country's economic growth, improved access to remote medical facilities, and rising awareness of auto-injectors in the country. The high prevalence of anaphylaxis in the United States leads to high adoption of generic epinephrine auto-injectors. With the availability of the generic EpiPen, a product of Mylan, at affordable price points, the sales volume of epinephrine autoinjectors is expected to increase in the US market, boosting the market growth. 

The outbreak of COVID-19 had a significant impact on the autoinjectors market in North America in 2020. However, in 2021, due to the large-scale vaccination drives implemented across the region, several business and industrial activities resumed, including the manufacturing of autoinjectors. Furthermore, the expansion of telemedicine services and the remote monitoring of patients has increased the demand for autoinjectors as patients require more convenient and accessible healthcare solutions. All these factors are expected to boost the growth of the autoinjectors market in North America during the forecast period. 

Segment Overview

The autoinjectors market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Application Outlook (USD Million, 2017 - 2027)
    • Anaphylaxis
    • Multiple sclerosis
    • Rheumatoid arthritis
    • Diabetes
  • End-User Outlook (USD Million, 2017 - 2027)
    • Hospital and clinics
    • Self-administration
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Argentina
      • Australia
      • Rest of the world

Parent Market Analysis

Technavio categorizes the global autoinjectors market as a part of the global pharmaceuticals market within the overall healthcare industry. The parent global pharmaceuticals market covers products and companies engaged in the R&D or production of generic drugs, non-generic drugs, and veterinary drugs. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.

Autoinjectors Market Scope

Report Coverage

Details

Page number

165

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 25.14%

Market growth 2023-2027

USD 134,014.58 million

Market structure

Fragmented

YoY growth 2022-2023(%)

24.1

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 41%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

AbbVie Inc., Amgen Inc., Bayer AG, Becton Dickinson and Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Halozyme Therapeutics Inc., Johnson and Johnson Services Inc., Johnson Medtech LLC, medmix Ltd., Merck KGaA, Owen Mumford Ltd., Pfizer Inc., RAVIMED Sp. zoo, Recipharm AB, SHL Medical AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed AG

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View the PDF sample

What are the Key Data Covered in this Autoinjectors Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the autoinjectors market between 2023 and 2027
  • Precise estimation of the size of the autoinjectors market size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of autoinjectors market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global autoinjectors market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global autoinjectors market 2017 - 2021 ($ million)
    • 4.2 Application Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Anaphylaxis - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Anaphylaxis - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Anaphylaxis - Year-over-year growth 2022-2027 (%)
    • 6.4 Multiple sclerosis - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
    • 6.5 Rheumatoid arthritis - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
    • 6.6 Diabetes - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Diabetes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Diabetes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Diabetes - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Diabetes - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by Application
      • Exhibit 50: Market opportunity by Application ($ million)
      • Exhibit 51: Data Table on Market opportunity by Application ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 54: Chart on Comparison by End-user
      • Exhibit 55: Data Table on Comparison by End-user
    • 7.3 Hospitals and clinics - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
    • 7.4 Self-administration - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Self-administration - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Self-administration - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Self-administration - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Self-administration - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by End-user
      • Exhibit 64: Market opportunity by End-user ($ million)
      • Exhibit 65: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 UK - Market size and forecast 2022-2027
      • Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 China - Market size and forecast 2022-2027
      • Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 AbbVie Inc.
              • Exhibit 115: AbbVie Inc. - Overview
              • Exhibit 116: AbbVie Inc. - Product / Service
              • Exhibit 117: AbbVie Inc. - Key news
              • Exhibit 118: AbbVie Inc. - Key offerings
            • 12.4 Amgen Inc.
              • Exhibit 119: Amgen Inc. - Overview
              • Exhibit 120: Amgen Inc. - Product / Service
              • Exhibit 121: Amgen Inc. - Key offerings
            • 12.5 Bayer AG
              • Exhibit 122: Bayer AG - Overview
              • Exhibit 123: Bayer AG - Business segments
              • Exhibit 124: Bayer AG - Key news
              • Exhibit 125: Bayer AG - Key offerings
              • Exhibit 126: Bayer AG - Segment focus
            • 12.6 Becton Dickinson and Co.
              • Exhibit 127: Becton Dickinson and Co. - Overview
              • Exhibit 128: Becton Dickinson and Co. - Business segments
              • Exhibit 129: Becton Dickinson and Co. - Key news
              • Exhibit 130: Becton Dickinson and Co. - Key offerings
              • Exhibit 131: Becton Dickinson and Co. - Segment focus
            • 12.7 Eli Lilly and Co.
              • Exhibit 132: Eli Lilly and Co. - Overview
              • Exhibit 133: Eli Lilly and Co. - Product / Service
              • Exhibit 134: Eli Lilly and Co. - Key offerings
            • 12.8 F. Hoffmann La Roche Ltd.
              • Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.9 GlaxoSmithKline Plc
              • Exhibit 140: GlaxoSmithKline Plc - Overview
              • Exhibit 141: GlaxoSmithKline Plc - Business segments
              • Exhibit 142: GlaxoSmithKline Plc - Key news
              • Exhibit 143: GlaxoSmithKline Plc - Key offerings
              • Exhibit 144: GlaxoSmithKline Plc - Segment focus
            • 12.10 Halozyme Therapeutics Inc.
              • Exhibit 145: Halozyme Therapeutics Inc. - Overview
              • Exhibit 146: Halozyme Therapeutics Inc. - Product / Service
              • Exhibit 147: Halozyme Therapeutics Inc. - Key offerings
            • 12.11 Merck KGaA
              • Exhibit 148: Merck KGaA - Overview
              • Exhibit 149: Merck KGaA - Business segments
              • Exhibit 150: Merck KGaA - Key news
              • Exhibit 151: Merck KGaA - Key offerings
              • Exhibit 152: Merck KGaA - Segment focus
            • 12.12 Owen Mumford Ltd.
              • Exhibit 153: Owen Mumford Ltd. - Overview
              • Exhibit 154: Owen Mumford Ltd. - Product / Service
              • Exhibit 155: Owen Mumford Ltd. - Key offerings
            • 12.13 Pfizer Inc.
              • Exhibit 156: Pfizer Inc. - Overview
              • Exhibit 157: Pfizer Inc. - Product / Service
              • Exhibit 158: Pfizer Inc. - Key news
              • Exhibit 159: Pfizer Inc. - Key offerings
            • 12.14 Recipharm AB
              • Exhibit 160: Recipharm AB - Overview
              • Exhibit 161: Recipharm AB - Business segments
              • Exhibit 162: Recipharm AB - Key offerings
              • Exhibit 163: Recipharm AB - Segment focus
            • 12.15 Teva Pharmaceutical Industries Ltd.
              • Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
            • 12.16 Viatris Inc.
              • Exhibit 169: Viatris Inc. - Overview
              • Exhibit 170: Viatris Inc. - Business segments
              • Exhibit 171: Viatris Inc. - Key offerings
              • Exhibit 172: Viatris Inc. - Segment focus
            • 12.17 Ypsomed AG
              • Exhibit 173: Ypsomed AG - Overview
              • Exhibit 174: Ypsomed AG - Business segments
              • Exhibit 175: Ypsomed AG - Key offerings
              • Exhibit 176: Ypsomed AG - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 177: Inclusions checklist
                • Exhibit 178: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 179: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 180: Research methodology
                • Exhibit 181: Validation techniques employed for market sizing
                • Exhibit 182: Information sources
              • 13.5 List of abbreviations
                • Exhibit 183: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              autoinjectors market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis